Autoregulation by the Juxtamembrane Region of the Human Ephrin Receptor Tyrosine Kinase A3 (EphA3)  by Davis, Tara L. et al.
Structure
ArticleAutoregulation by the Juxtamembrane Region of the
Human Ephrin Receptor Tyrosine Kinase A3 (EphA3)
Tara L. Davis,1,2 John R. Walker,1 Peter Loppnau,1 Christine Butler-Cole,1 Abdellah Allali-Hassani,1
and Sirano Dhe-Paganon1,2,*
1Structural Genomics Consortium
2Department of Physiology
University of Toronto, Toronto, Ontario M5G 1L5, Canada
*Correspondence: sirano.dhepaganon@utoronto.ca
DOI 10.1016/j.str.2008.03.008SUMMARY
Ephrin receptors (Eph) affect cell shape and move-
ment, unlike other receptor tyrosine kinases that
directly affect proliferative pathways. The kinase
domain of EphA3 is activated by ephrin binding and
receptor oligomerization. This activation is associ-
ated with two tyrosines in the juxtamembrane region;
these tyrosines are sites of autophosphorylation and
interact with the active site of the kinase to modulate
activity. This allosteric event has important implica-
tions both in terms of understanding signal transduc-
tion pathways mediated by Eph kinases as well as
discovering specific therapeutic ligands for receptor
kinases. In order to provide further details of the
molecular mechanism through which the unphos-
phorylated juxtamemebrane region blocks catalysis,
we studied wild-type and site-specific mutants in
detail. High-resolution structures of multiple states
of EphA3 kinasewith andwithout the juxtamembrane
segment allowed us to map the coupled pathway of
residues that connect the juxtamembrane segment,
the activation loop, and the catalytic residues of the
kinase domain. This highly conserved set of residues
likely delineates a molecular recognition pathway for
most of the Eph RTKs, helping to characterize the
dynamic nature of these physiologically important
enzymes.
INTRODUCTION
The Eph family is the largest subgroup of receptor tyrosine
kinases (RTKs), playing major roles in development, directing
segmentation, axon guidance, fasciculation, angiogenesis, and
limb development (O’Leary and Wilkinson, 1999). These type I
transmembrane proteins contain an extracellular ligand-binding
domain, two type III fibronectin domains, and two intracellular do-
mains: the tyrosine kinase and sterile-alpha-motif (SAM) domains
(Figure 1A). Eph ligands, known as ephrins, are tightly associated
with membranes either through glycosylphosphatidylinositol
(GPI)-linkage (type A ephrins) or single transmembrane spanning
regions (type B ephrins).Ephrin ligands are typically expressed onStructurecells other than those that express receptors; interaction between
Eph- and ephrin-containing cells leads to bidirectional signaling,
a series of events that either stabilize cell-cell contact or lead to
cell repulsion. Downstream signaling from Eph receptors has
been associated with cell shape via Rho activation, cell growth
via the MAPK pathway, cell-cell adhesion via cadherin com-
plexes, and cell-matrix interactions via integrin complexes (Noren
and Pasquale, 2004; Pasquale, 2005; Poliakov et al., 2004).
EphA3 (Hek/Hek4/Etk/Etk1/Tyro4) was initially characterized
during analysis of the retinotectal mapping of neurons (Kilpatrick
et al., 1996; Lai and Lemke, 1991) and was later found to be
expressed in brain, muscle, lungs, and kidney (Kilpatrick et al.,
1996). ephA3 null mice develop abnormal hearts, leading to
postpartum death (Stephen et al., 2007). EphA3 has also been
found in somatic mutations of human cell lines of lung and colon
cancers, and it was recently found up-regulated in response to
hypoxia in cultured bone marrow embryonic stem cells. This
finding places EphA3 in a functional group with growth factor
regulated RTKs, including VEGFA and VEGFC (Wood et al.,
2006; Martin-Rendon et al., 2007). The activity of the kinase do-
mains of Eph receptors is regulated via autorepression by their
juxtamembrane region, which contains two autophosphorylation
sites (Wybenga-Groot et al., 2001; Binns et al., 2000). Through
crystallographic analysis of a double mutant of EphB2, it was
proposed that the juxtamembrane segment (JMS), bound
between the N- and C-terminal lobes, prevents ordering of the
activation loop (AL), clamping of the lobes, and kinking of the
N-terminal lobe helix aC, all of which thwart the catalytic transi-
tion state (Wybenga-Groot et al., 2001). The structure of a triple
mutant of EphA4 supported this model of activation by the
observation that disordering of JMS occurred upon mutational
activation of the kinase (Wiesner et al., 2006). A recent deletion
mutant structure of EphA2, on the other hand, suggested an un-
coupling of the juxtamembrane and catalytic functions (Nowa-
kowski et al., 2002). Finally, using solution-based NMR methods,
the dynamic nature of the N-lobe relative to the C-lobe was pro-
posed to be the target of JMS-mediated regulation of EphB2
(Wiesner et al., 2006).
To provide a more detailed and specific analysis of the autor-
egulatory mechanism in EphA3 kinase, we conducted compre-
hensive structure-function studies of wild-type EphA3. We
analyzed the structural significance of the JMS in relation to
the catalytic domain and characterized several mutations in the
JMS and AL. These data reveal a complex mechanism of regula-
tion involving several residues that connect the juxtamembrane16, 873–884, June 2008 ª2008 Elsevier Ltd All rights reserved 873
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Structure of EphA3Figure 1. Constructs Used in the Current Study and Alignment of EphA3 with Selected Eph RTKs
(A) Graphical representation of EphA3; domains referenced in the text are labeled and colored. Residues highlighted in the text are also labeled. Below, a graphical
representation of the constructs and mutants described in the text.
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Structure of EphA3region to the active site of EphA3. The ability to work with the
wild-type version of EphA3 enzyme allowed direct structural
analysis of the conformational changes adopted by EphA3 dur-
ing the progression from unphosphorylated to fully phosphory-
lated enzyme in a more detailed and rigorous way than previous
structures based on mutant constructs. We describe pathways
connecting the JMS to the AL and the JMS to the dynamics of
the catalytic domain, thereby elucidating several novel features
of these physiologically relevant proteins heretofore unrecognized.
RESULTS AND DISCUSSION
Overall Description of Structures
To evaluate the mechanism of action and autoregulation of
EphA3, we determined structures of wild-type, deletion, and
site-specific mutants. Wild-type proteins (JMKIN) were initially
crystallized as isolated from the Escherichia coli host (base) as
partially phosphorylated species, or later after pretreatment
with either ATP and magnesium (ATP) to fully phosphorylate the
protein or with calf intestinal phosphatase (CIP) to fully dephos-
phorylate it. In addition, cocrystallization trials with or without
AMP-PNP (ANP or apo) were performed on all forms of the
wild-type JMKIN, leading to the determination of the five wild-
type JMKIN structures described in this study (Table 1). Two
more structures were determined of EphA3 in which the JMS
was deleted, either with or without AMP-PNP (KIN-apo and
KIN-ANP) (Table 1). In addition, the current work describes the
structures of seven mutant kinases based on the JMKIN con-
struct (Table S1, see the Supplemental Data available with this
article online). See Figure 1A for a graphical representation of
constructs and mutants used in the current study. All structures
were determined to better than 2.0 A˚ resolution with Rfree no
higher than 22% (Table 1 and Table S1), and all atoms described
as being ordered in this study have main-chain B-factors less
than 80 A2. All structures adopt the canonical protein kinase bilo-
bal fold (Figure 2A). The amino-terminal lobe consists of twisted
five-strand antiparallel b sheets and a single helix aC; the car-
boxy-terminal lobe is mostly a-helical (Figure 2A). The structure
of the wild-type EphA3 is globally quite similar to the structures
of EphA4 and EphB2 solved previously, although the EphA4
and EphB2 structures are mutated in the JMS region and else-
where (Figure 2B; Wiesner et al., 2006). Structural changes
within the JMS and SAM linker region between EphA3 and other
Eph kinase structures are observed and discussed in further de-
tail below. For EphA3, global conformational changes do not oc-
cur between apo and nucleotide-containing structures apart
from the expected small clamping motion by theb1-G loop-b2 re-
gion in the N-terminal lobe (Figure 3 and Figure S1A); the rmsd
among Ca carbons excluding the JMS and AL regions for apo
and ANP structures was 0.44 A˚. ANP structures showed adeno-
sine binding in the canonical pocket with alternative conforma-
tions adopted by the b and g phosphate moieties, similar to the
case described previously for Pim1 kinase (Qian et al., 2005;Figure S1A). Magnesium atoms are chelated by the b and gphos-
phate groups of AMP-PNP and by the side chains of the catalytic
residues Asn751 and Asp764. The overall structure of the KIN
protein was unaffected by deletion of the JMS; the substrate
binding face of the amino-terminal lobe clamps down on the nu-
cleotide with the amino-terminal portion ofaC moving about 0.5 A˚
and strands b1 and b2 moving toward the C-lobe about 0.6 A˚ and
1 A˚, respectively (Figure S1A). In summary, differences between
the wild-type structures occur mainly in the N-terminal region of
the AL and the N-terminal region of the JMS.
Structure of the C-Terminal Extension
Carboxy-terminal to the kinase domain of all Eph RTKs is a small
domain identified as the sterile alpha motif (SAM). These 70
amino acid domains are found in all eukaryotes and some bacte-
ria; although the fold seems to be well conserved, on the basis of
the structures that have been solved to date, SAM domains
seem to perform divergent functions in the thousand of proteins
in which they are found, and in many cases no function has been
assigned to the SAM domain in particular proteins (Kim and
Bowie, 2003). The SAM domains of Eph RTKs have been pro-
posed on the basis of structural data of the SAM domain alone
to mediate oligomerization of the receptor (Stapleton et al.,
1999). It is of great interest to the field to understand the struc-
tural relationship between the kinase domain and the SAM
domain. Although our EphA3 constructs did contain the SAM do-
main, this region of the protein degraded prior to crystallization;
however, the crystals do contain the linker between the kinase
and SAM domain and it is partially ordered in most of our struc-
tures (Figure 2B). Although residues 895–898 are unstructured in
most of our models, residues 899–904 interact tightly as an ex-
tended peptide in an unprecedented interaction with the basal
face of the C-terminal lobe, which includes regions of helices
aG and aH and the adjoining loops (Figure 4). The side chains
of Leu901 and Asp904 are accommodated in complimentary
pockets formed by aG and aH of the kinase domain and interac-
tions include three backbone-backbone hydrogen bonds of less
than 3.0 A´ with the aGH loop (residues Tyr841–Pro846). Leu901
of EphA3 occupies a deep pocket formed by residues from the
aGH loop, and consequently Tyr841 at the C-terminal of aG in
EphA3 is flipped out. This rather unique conformation of
Tyr841 is stabilized by a clamping effect of the adjacent side
chains Leu901 and Leu903 of the linker (Figure 4). Although the
aromatic residue in the paralogous EphA2 structure is also flip-
ped out, leaving an empty pocket (PDB code: 1MQB, residue
Phe834), the corresponding residues in EphB2 (PDB code:
1JPA, residue Tyr851) and EphA4 (PDB code: 2HEL, residue
Tyr841) are not; however, none of these structures contains its
homologous C-terminal extensions. That the linker between
the kinase and SAM domains is bound at the base of the kinase
C-lobe and that the dual leucines in this linker and the aromatic
residue they interact with are highly conserved among members
of the Eph family suggests a functional significance. Since there(B) Alignment was performed using ClustalX (Thompson et al., 1997), and the cytosolic region roughly corresponding to the JMKIN boundaries were used for the
alignment. Conserved residues are color-coded according to chemical property if there is at least 90% identity at that position. In addition, identity is marked
above the alignment as follows: asterisk (absolute conservation), colon (conservative substitutions), and period (semiconserved substitutions). Secondary struc-
tural elements are labeled and shown graphically above the alignment and the positions of the JMS, AL, and the linker region between the kinase and SAM
domains are indicated. Numbering corresponds to human EphA3.
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Structure of EphA3Table 1. Crystallographic Statistics for Wild-Type EphA3 and for Six Subsequent Wild-Type Structures of EphA3
Construct JMKIN JMKIN JMKIN JMKIN JMKIN JMKIN KIN KIN
Pre-treatment base base CIP CIP base ATP base base
ligand nil nil nil ANP ANP ANP nil ANP
Data collection
Beamline RU-200-
Chromium
FRE-HR FRE-HR FRE-HR FRE-HR FRE-HR FRE-HR CHESS A1
Wavelength 2.29 1.54178 1.54178 1.54178 1.54178 1.54178 1.54178 0.979
Resolution 20–2.3 20.0–1.75 20.0–1.6 25–1.60 40–1.60 20–1.55 20.0–1.649 50.0–1.25
Unique reflections
Reflections
13183 29945 37114 37319 37433 42955 35314 84007
Data redundancy (High
resolution Shell)
19.5 (8.4) 6.8 (6.4) 3.5 (2.3) 2.6 (1.6) 6.6 (4.5) 5.9 (4.4) 6.8 (6.4) 3.6 (3.3)
Completeness, % 94.8 (62.5) 95.8 (64.5) 90.7 (51.6) 92.5 (49.2) 91.7 (48.7) 98.4 (92.2) 95.8 (64.5) 99.6 (98.6)
I/sigIa 45.9 (8.3) 48.8 (21.6) 39.8 (12.3) 12.2 (1.34) 30.8 4.5) 36.4 (12.5) 48.8 (21.6) 26.0 (3.8)
Rsym
b 0.10 (0.21) 0.031 (0.032) 0.031 (0.085) 0.045 (0.464) 0.052 (0.175) 0.038 (0.134) 0.031 (0,032) 0.050 (0.25)
Refinement
Resolution 1.77 1.60 1.60 1.60 1.55 1.65 1.25
Number of reflections 28392 37087 37308 37417 42955 35314 82459
All atoms (solvent) 2497 (264) 2688 (335) 2576 (240) 2586 (251) 2741 (418) 2695 (304) 2952 (427)
Rwork (Rfree)
c 0.16 (0.19) 0.176 (0.203) 0.184(0.224) 0.189(0.219) 0.182(0.211) 0.169 (0.196) 0.169 (0.186)
Rmsd bond length 0.014 0.008 0.009 0.008 0.012 0.008 0.007
Rmsd bond angle 1.41 1.182 1.287 1.192 1.375 1.134 1.673
Ramachandran plot
Most favored, % 90.5 91.4 90 88.5 91.3 91.3 90.7
Additionally allowed, % 8.6 7.4 9.2 10.7 7.9 8.3 8.9
Generously allowed, % 0.8 1.2 0.8 0.8 0.8 0.4 0.4
Disallowed, % 0 0 0 0 0 0 0
PDB code 2GSF 2QO2 2QO7 2QOQ 2QO9 2QOB 2QOC
Modeled residues 595–600;
609–770;
787–893;
899–904
595–600;
603–766;
787–892;
899–904
595–600;
608–766;
787–893;
898–904
595–600;
603–766;
785–892;
900–906
608–771;
785–892;
900–904
609–771;
785–892;
897–906
613–773;
785–906
Density for phosphate on residue
Y596 no no no no disordered n/a n/a
Y602 disordered disordered disordered disordered disordered n/a n/a
Y701 no no yes yes no yes no
Atomic coordinates have been deposited into the RCSB for 2GSF (JMKIN base apo); coordinates for all other structures discussed in the text have
been deposited into the RCSB and PDB codes are listed in the Experimental Procedures and in the table. JMKIN is a construct containing residues
577–947 and KIN contains residues 606–947. All structures are in space group P21 with unit cell dimensions of 53.790, 38.337, 76.439, 90.00, 102.07,
90.00, (±1%).
a Highest resolution shell is shown in parenthesis.
b Rsym = 100 3 sum(jI  < I > j)/sum(<I >), where I is the observed intensity and < I > is the average intensity from multiple observations of symmetry-
related reflections.
c Rfree value was calculated with 5% of the data.are only four residues between the conserved dual leucine motif
and the beginning of the core SAM domain, the presence or
absence of kinase-bound dileucine motif could have significant
effects on the relative orientation between these domains.
Further experiments are under way to determine the significance
of this interaction.
Autophosphorylation of Tyr701
Fully unphosphorylated EphA3 could be expressed and purified
out of E. coli by coexpression with a plasmid expressing lambda876 Structure 16, 873–884, June 2008 ª2008 Elsevier Ltd All rights rphosphatase (data not shown). However, the kinase protein as
originally isolated from E. coli lysates contained a mixture of
one to three phosphorylation events; treatment with excess
ATP and magnesium resulted in an additional phosphorylation
event (relating to the masses of a maximum of four phosphotyr-
osines) as observed by ES-TOF/MS. Since only three phosphor-
ylation sites for EphA3 would have been predicted on the basis of
other Eph isoform studies (Binns et al., 2000), peptide mapping
by matrix-assisted laser desorption quadrupole time-of-flight
mass spectrometry (MALDI qTOF MS/MS) was performed oneserved
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Structure of EphA3tryptic digests of the purified base and ATP-pretreated JMKIN
samples. The base samples contained three phosphorylated
peptide sites: one JMS peptide that contained both JX1 and
JX2 with mass corresponding to a single phosphorylation event,
another corresponding to phosphorylation on Tyr779, and a third
containing a phosphorylation of a novel residue, Tyr701 (Table
S2). The ATP-treated samples contained the same set as well
as a doubly-phosphorylated JMS peptide (Table S2), which is
consistent with kinase activation and our observation that ATP
pretreatment causes structural disorder of the JMS. In line with
other studies, the activation loop tyrosine, Tyr779, is autophos-
phorylated (Binns et al., 2000; Kalo et al., 2001); the structures
in this study unfortunately do not help reveal the conformational
consequence of this phosphorylation event as the electron den-
sity in this region is always uninterpretable. Surprisingly, mass
spectral data clearly shows that a novel tyrosine is phosphory-
lated: Tyr701 (Table S2). This observation was confirmed by
well-defined electron density and good occupancy for a phos-
phate group on Tyr701 in a number of our structures (Figure 3;
Table 1). Tyr701 occurs at the pivot point between the N- and
C-terminal kinase lobes, opposite the JMS. The aromatic group
of Tyr701 is within van der Waals contact of Cb atoms of Ser637-
and Ser649 (N-terminal lobe b1) and Glu703 (C-terminal lobe b5),
and it is also within van Der Waals distance of the adenine moiety
of the nucleotide, seemingly shielding the nucleotide from
solvent (Figure 3). The phosphate group of Tyr701 forms two
water-mediated hydrogen bonds with Ser637 and is sandwiched
between two positively charged patches, one in the N-terminal
lobe centered about the epsilon amino group of Lys625 and
another in the C-terminal lobe around residue Lys713. The posi-
tion of Tyr701 is practically invariant whether phosphorylated or
not, or whether nucleotide is bound or not. In fact, the rmsd over
all atoms of residues in the hinge region (residues 700–707) for all
fourteen of our structures ranges from 0.068 to 0.193A˚. This
structural similarity implies that the function of phosphorylation
of Tyr701 is unlikely to involve large changes in nucleotide bind-
ing or catalytic efficiency of the enzyme. On the other hand,
Tyr701 is conserved in EphA2, 3, and 4, and substituted to phe-
nylalanine in EphA1, 7 and all EphBs (Figure 1B), which suggests
a potential role for phosphorylation of this residue in many of the
EphA isoforms. However, mutation of Tyr701 to a phenylalanine
does not significantly affect either the activity of the kinase
domain against substrate (data not shown), and only slightly
increases the Km for ATP (139 ± 9 mM for wild-type versus 229 ±
41 mM for Y701F; Figure S4). Therefore, although Y701 is a vali-
dated site for EphA3 autophosphorylation, it is unclear what
function this phosphorylation event may have in signaling, if any.
Relationship between JMS and AL
In summary, differences between the wild-type structures occur
mainly in the N-terminal region of the AL and the N-terminal region
of the JMS. The extent to which the AL and JMS were ordered in
each construct is therefore the main focus of this study. Confor-
mational differences between the wild-type EphA3 structures
together with activity measurements revealed novel details into
the mechanism by which the JMS regulates catalytic activity.
Five structures of JMS-containing and two structures of JMS-
deleted derivatives of EphA3 were determined, most with and
without nucleotide. Except for the segment surrounding JX2
(Tyr602), which is disordered in most of our structures, the con-
formation of the JMS matches closely with that of the dominant
negative Y604Y608:FF double mutant of EphB2 (PDB code:
1JPA; Figure 2B). Notably, JX1 (Tyr596) is nestled in a pocket
between the N- and C-terminal lobes, making significant van
der Waals contacts with the aC residues Ile673, Asn676, and
Phe677, as well as Tyr742 in the loop C-terminal to aE of the
C-lobe, very similar to the structure of Y604F in EphB2 (Figures
2 and 5). The hydroxyl group of Tyr596 in our structures often
forms a hydrogen bond with the carboxyl group of the i+3 residue,
Asp598 (Figure 5C). Notably, one of the wild-type structures of
EphA3 shows the conformation of the wild-type JMS region for
the first time, to our knowledge, as previous structures of the
Eph kinases have either complete disorder of this region, or are
mutated from tyrosine to phenylalanine. Electron density for
JX2 is generally poor and disconnected, but in at least one struc-
ture it seems that Tyr602 and its neighboring residues (HTY602XD)
Figure 2. Overall Structure of EphA3 Kinase
All molecular graphics figures were generated us-
ing PyMOL unless noted.
(A) Cartoon representation of the EphA3 JMKIN
base ANP structure. The structure is shown in
forest green and in cartoon representation. Sec-
ondary structure elements and regions discussed
in the test are labeled. Regions of disorder are
indicated with dashed lines. This structure was
chosen because it represents the highest degree
of order modeled for all the EphA3 structures.
(B) Ribbon representation of JMKIN base ANP
overlaid with EphB2 in pink (1JPA). Alignment
over all atoms yields an rmsd of less than 1A˚ for
all structures; key regions of structural difference
occur in the N-terminal lobe, centered on the
JMS and the AL, along with slight differences in
the b1-G loop-b2 region.
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Structure of EphA3are solvent exposed. The fact that JX2 is consistently disordered
in the Y602F and YYFF structures (described in more detail
below) implies that this side chain is still pointing out into solvent
instead of packing against aC as in the case of EphB2. Therefore,
although JX2 of EphB2 has been suggested to act in concert with
JX1 to stabilize the interaction of the JMS against the core of the
kinase domain when unphosphorylated, the role of the EphA3
JX2 (Tyr602) in autoregulation is unclear but would seem to func-
tion in some other fashion; it is possibly a conserved docking site
for downstream signaling factors that contain phosphotyrosine-
binding domains.
An important element of the current model of JMS-mediated
regulation in Eph kinases involves the relationship between the
JMS and the AL, which at the crystallographic level is often
observed as a partial ordering of the AL upon JMS removal
(Wiesner et al., 2006; Wybenga-Groot et al., 2001). As expected,
pretreatment with ATP resulted in the ordering of the AL region in
our EphA3 structures as well (Figure 5). The conformation of the
AL, typified by the liganded KIN structure, runs as a b sheet an-
tiparallel to b6. Notable side chain interactions include van der
Waals contact between Leu767 and Ile786, hydrogen bonding
between the carbonyl of Leu767 and the guanidine group of
Arg745, clashing of Ser768 with Tyr742 (discussed in detail in
this text), and van der Waals interactions between Val771 and
Ile730. The majority of our structures are consistent with the
current regulatory model: the extent to which the AL after the
absolutely conserved DFG segment is structured is generally
correlated with the phosphorylation state of the protein and the
absence of JMS density. Notably, the conformations adopted
by the AL and the JMS, regardless of construct, are generally su-
perimposable. It is interesting that the structural order to disorder
Figure 3. Tyr701 Is an Autophosphorylation
Site in EphA3
The model for the JMKIN base ANP structure is
shown in cartoon and stick representation and col-
ored forest green. The 2Fo-Fc density for phospho-
tyrosine701 (PTR701) and the ANP nucleotide in
the active site in the JMKIN base ANP structure
is contoured at 0.9s. An orientation is shown that
best reveals the density and position of the
PTR701 relative to the nucleotide. Residues con-
tributed by the b1 strand and G loop in the N-ter-
minal lobe and others which line the nucleotide
binding site are shown in stick representation.
transitions in the AL do not seem to corre-
late with conformational flexibility, in the
sense that when ordering in the AL oc-
curs, it adopts the same conformation,
more like an on/off switch than the floppy
loop that one might expect. For phospha-
tase-treated samples, which have a well-
defined JMS, the AL is ordered only up to
DFG766 and residues Leu767–Ile786 are
disordered (Figure S2). In untreated sam-
ples that are partially phosphorylated, the
JMS is still ordered and AL density is
seen through Val770 (DFGLSRV770). For
ATP-treated samples that are fully phosphorylated, the JMS is
disordered and the AL is most structured to residue Asp773
(DFGLSRVLED773) (Figure 5). No structures revealed density
for the C-terminal segment of the AL, including the AL tyrosine
779 (residues D774PEAAYTTRGG784). To further test whether
conformational flexibility of the AL loop is affected by the pres-
ence of the JMS, we determined two high resolution structures
of an EphA3 construct that excluded the JMS, with and without
ANP (called KIN apo and KIN ANP). In both these structures, the
N-terminal AL is ordered to a large extent, with density extending
to Leu771 and Asp773 respectively (Figures S2C and S2D). It
should be noted that in these structures, it is possible to measure
the effect of crystal contacts on the ordered state of the AL, in the
sense that by looking at the KIN ANP model (2QOC) gives an op-
portunity to measure the closest contacts between symmetry
mates. For the C-terminal AL, the closest symmetry relatives
are 10A˚ away; however there are relatively close contacts
(5–6 A˚) between the N-terminal AL region and residues 712–
713 (aD region) of a symmetry-related molecule. We cannot
say for certain whether this contact region is prohibitive in terms
of AL order; in any case, the presence of a well-defined N-termi-
nal AL is correlated with the absence of the JMS in our struc-
tures. This finding supports the current regulatory model, where
unphosphorylated JMS inhibits catalysis by preventing the AL
from reaching a conformation that is compatible with the transi-
tion state.
Pretreatment with ATP resulted in the disordering of the JMS
region in the EphA3 structures as expected. The conformation
of the AL making direct contact with JMS (LSRV770) remains un-
changed whether the JMS is ordered or not (see JMKIN base
apo, JMKIN ATP ANP, and KIN apo or KIN ANP structures;
878 Structure 16, 873–884, June 2008 ª2008 Elsevier Ltd All rights reserved
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Structure of EphA3Figure 5 and Figure S2). It is worth mentioning that disorderering
of the JMS through phosphorylation results in only minor
changes in the structure and orientation of the N-terminal lobe
as seen previously by NMR (Wiesner et al., 2006). It is perhaps
more relevant that a rotamer position, whereby the side chain
of Tyr742 rotates away from the core domain toward the solvent,
becomes highly populated when the JMS is absent (Figure 5C
and Figures S2C and S2D). However, some EphA3 structures in-
dicate that the structural order/disorder correlation between the
AL and JMS regions and kinase activation is not binary; for in-
stance, the AL and JMS are simultaneously ordered in the basal
apo JMKIN structure (Figure 5B). In several EphA3 data sets
(ATP-pretreated nucleotide-bound JMKIN and both nucleo-
tide-bound and nucleotide-free KIN structures), the density for
two rotamers for Tyr742 is clearly seen (Figure 5 and
Figure S2). Conspicuously, for several EphA3 structures in an
‘‘active’’ conformation (JMKIN base apo, JMKIN ATP ANP, and
both KIN structures), the hydroxyl group of Tyr742 overlaps
with the hydroxyl group of Ser768 with only 1.6 A˚ between the
well-defined densities of the Cb Ser768 and C3 of Tyr742 (Fig-
ure 5 and 6 and Figure S2). Despite repeated attempts, we could
not refine these side chains to alleviate the steric clash without
seeing large residual densities in this region, indicating that the
steric clash conformations indeed correctly modeled our exper-
imental density. This apparent clash, although probably resulting
from a mixture of rotamer conformations present in the crystals
as opposed to an actual populated state, suggests a potential
molecular pathway by which the JMS could directly affect the
AL. If the AL of unphosphorylated EphA3 is disordered and the
AL of phosphorylated EphA3 is ordered, then regulation could in-
volve displacement or adjustment of the AL through steric inter-
ference between the hydroxyl group of Tyr742 and the hydroxyl
group of Ser768. Our multiple structures along the activation
pathway allowed isolation of the potential function of Tyr742;
for instance, it adopted both rotamers whether nucleotide was
present or absent. In addition, the N-terminal portion of the AL
(LSRV770) was ordered in the canonical conformation in the
structures of the KIN domain without the JMS, indicating that
the JMS was not necessary for the AL conformation seen in
our structures to occur; furthermore, the hydroxyl group of the
rotamer facing Ser768 clashed with the hydroxyl group of Y742
in both KIN structures. Taken together, these findings suggest
that the vital connection that Y742 makes between the JMS
and AL regions may be functioning as an ‘‘activation sensor’’
constantly transmitting information about the JMS conformation
to the AL region regardless of nucleotide bound status.
The analysis of our EphA3 structures also reveals that residues
Asp598 and Pro599 in the JMS are disordered only when Tyr596
is bound to the kinase domain and the AL is partially disordered
(Figure 5 and Figure S2), suggesting that these residues might
also be important in the regulatory mechanism. Minor clashing
would be expected to occur between the side chains of
Asp598 of the JMS and Val770 in the AL, where methyl groups
of Val770 would be within 2.5 A˚ of Asp598 if they were simulta-
neously ordered in our structures (Figure 5). In addition, our
Figure 4. The Linker Between the Kinase and SAM Domains Binds
into a Complementary Pocket on the C-terminal Lobe of the Kinase
Domain
An electrostatic surface was generated using APBS (Baker et al., 2001) using
a gradient from10 to 10 keT. Shown in cartoon and stick representation is the
model for KIN ANP in firebrick red; this model contains the most ordered linker
region comprising residues 885–906. Highlighted is the complementary sur-
face made up by Tyr841, Leu901, and Leu903.
Figure 5. Rotamer Position of Y742 and
S768 in VariousWild-Type EphA3Structures
The region including the aE-b6 and b7-N-terminal
AL region are highlighted in each panel.
(A) JMKIN base ANP. In the ANP-PNP bound un-
treated structure, shown in forest green, Tyr742
and Tyr596 are in a single and complementary
stacking conformation; the AL shows a relatively
high degree of disorder, and the conformation of
Ser768 is undetermined. This structure is consid-
ered an ‘‘off’’ conformation of the enzyme.
(B) The JMKIN base apo structure, in teal, shows
the clash between a single rotamer of Ser768 and a single rotamer of Tyr742. Part of the JMS is present, showing the relationship between Tyr742 and JX1
(Tyr596). This structure is considered an intermediate low-activity conformation in our analysis.
(C) JMKIN ATP ANP. In this example of a high-activity conformation, shown in goldenrod, both Ser768 and Tyr742 are in dual rotamer positions. The JMS is
completely disordered in this structure.
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between residues Asp598–His600 and the AL residues C-termi-
nal to Asp774, were they to be simultaneously ordered in a struc-
ture.
Flexibility of the N-terminal lobe relative to the C-terminal lobe
has been shown to be restricted by the interaction of the JMS in
the case of EphB2 (Wiesner et al., 2006). To see whether this is
also true for EphA3, we analyzed the B-factors of our wild-type
structures. Although conformational variation in the N-terminal
lobe of apo-structureswas large, particularly in theb1–b3 strands,
a much more homogenous population of structures was ob-
served for nucleotide bound crystals, regardless of the phosphor-
ylation state or presence/absence of JMS (Figure 7). The latter
structures presented the most closed form of the N-terminal
lobe, where the Ca of Gly628 in the b1 strand was within only
10.6 A˚ away from the Ca of Ser706 at the floor of the nucleotide
binding pocket. This distance in the most open, apo structure
was 4.2 A˚ longer. B-factor values were normalized in the C-termi-
Figure 6. Density of the Ser768:Tyr742
Clash Region
The structure of JMKIN ATP ANP is shown in car-
toon and stick representation and colored golden-
rod. 2Fo  Fc density for the Ser768:Tyr742 clash
region is shown in teal, contoured at 0.9s. Com-
plete density is observed for both rotamers of
Ser768, and nearly complete density is observed
for both Tyr742 rotamers.
Figure 7. B-Factor Analysis of EphA3
Structures
(A) Shown is a graph representing the greatest
variance in B-factors between wild-type EphA3
structures, after normalization of the main chain
values against a reference structure. The high-
lighted region corresponds to the b1–b2 region,
which closes down upon the nucleotide and sub-
strate binding pocket upon kinase activation and
substrate binding. The normalized B-factor for
this region increases in order of increasingly active
structure, with the JMS containing and dephos-
phorylated structure considered inactive and the
JMS deleted ANP bound kinase structure consid-
ered the most active.
(B) Shown is an overlay of the seven wild-type
EphA3 kinase models, colored by B-factor values.
The B-factors are separated into 5 bins, colored in
increasing order from blue (less than 15 A˚2) to red
(greater than 31 A˚2). Clearly, the N-terminal lobe
dominates in terms of B-factor considerations,
and the b1-G loop-b2 region is again highlighted
with the highest overall B-factors for all structures.
nal regions of nucleotide-bound struc-
tures and the B-factors values of the
N-terminal lobe were compared. For all
liganded structures, straightforward nor-
malization resulted in B-factors of 18 ± 5
A˚2 for all residues in secondary structure
elements between 700 and 880 (data not
shown). This analysis showed increasing
relative B-factors values in the N-terminal lobe of CIP-pretreated,
basal, ATP-pretreated, and JMS-lacking structures, a series of
states corresponding to increasingly active enzyme. This correla-
tion was particularly evident for the b1–b2 strands (Figure 7). Re-
moval of the JMS, whether through phosphorylation or deletion,
dramatically increases the flexibility and/or dynamics of the N-ter-
minal lobe. Consistent with solution studies (Wiesner et al., 2006),
our results suggests that as the enzyme moves closer to an active
state, flexibility becomes a dominating characteristic.
Mutations that Uncouple JMS Regulation
of EphA3 Kinase
To disengage the inhibitory effect of the JMS on the enzyme, mu-
tations were generated in the YYFF (Y596F, Y602F) autoinhibited
background, and their activities and structures were determined.
Confirming previous conclusions from other Eph kinases, the
YYFF double mutant resulted in a 10-fold suppression of cata-
lytic activity, compared with wild-type protein, when a peptide
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Structure of EphA3derived from JX2 (D598PHTYEDPTQ606) was used as substrate
(Figure 8A; Wybenga-Groot et al., 2001; Binns et al., 2000). Con-
comitantly, the YYFF structure exhibited typical characteristics
of an inactive kinase in terms of JMS order and AL disorder
(Figure S3). The individual JMS mutants were also prepared.
The single Y602F mutant did not have lowered catalytic activity
compared with wild-type, which is consistent with the nearly
complete absence of density for this residue in our wild-type
and mutant structures and again suggests that it does not
appear to play a major role in the regulatory mechanism. This
is in slight contrast to the EphB2 JX2, whose mutation to phenyl-
alanine had a greater effect on kinase activity and was directly
implicated in stabilization of the autoinhibited form (Binns
et al., 2000). That the single Y596F mutant was also partially
active, compared with wild-type, suggests that other elements
besides Tyr596 are important components in the regulation of
kinase activity by the JMS. Nevertheless, contribution to the reg-
ulatory mechanism is suggested by the double mutant (Y596F,
Y602F), which was a much poorer enzyme compared to the
single Y596F mutant (Figure 8A). Notably, the two single JMS
mutants and the double JMS mutant showed identical struc-
tures: the JMS was in place and the AL was visible only up to
Phe765 (Figure S3). This structural finding indicates that muta-
tion of the JMS does not significantly affect the order/disorder
transitions of EphA3 kinase in this crystal form; this is an as-
sumption that is often made for this class of enzyme but may
not always be valid.
To establish that Tyr742 is part of the regulatory switch as
suggested by our wild-type structures, it was mutated to either
phenylalanine or alanine in the YYFF autoinhbited background.
Both mutants regained activity: YYFF:Y742F was equally active
as wild-type, and YYFF:Y742A had an activity two-fold greater
than wild-type (Figure 8A). Consistent with the regulatory func-
tion, Km values remained unaffected by mutations and differ-
ences were expressed mostly though kcat values (data not
shown). This is in contrast to the previously described EphA4
YYFF:Y742 mutants, in which the Y742A mutant was active but
the Y742F mutant was not. To determine how these mutations
caused reactivation of the enzyme, we determined both the
EphA3 YYFF:Y742A and YYFF:Y742F structures to high resolu-
tion. Notably, the JMS remained in place, which is in contrast to
the EphA4 triple mutant structure (Wiesner et al., 2006). Although
both EphA3 triple mutants are catalytically competent in our
hands, the structure of the triple mutant YYFF:Y742A showed
an ordered AL but the triple mutant YYFF:Y742F did not (Fig-
ure 8B). The AL of YYFF:Y742A adopts the canonical conforma-
tion, where Ser768 is unimpeded by the mutant Ala742, filling an
otherwise empty cavity. The structure of the YYFF:Y742F mutant
was superimposable with the YYFF dominant negative. In EphA3,
reactivation occurs not by disassociation of the JMS, as seen in
the EphA4 structure (Wiesner et al., 2006), but by uncoupling
Tyr742 from the AL, presumably by allowing Ser768 freedom to
adopt catalytically active conformations in the C-terminal AL
region (Figure 8B and Figure S3).
To test whether Ser768 is an important gateway through which
the JMS and Tyr742 function, Ser768 was mutated to either ala-
nine or glycine in the inhibited YYFF background. The catalytic
activity of the YYFF mutant was rescued with the presence of
the S768A mutation (Figure 8A) and the structure of this triple
mutant showed a well-ordered JMS and AL (Figure 8B). Though
a slight shift in backbone positioning of Ala768 occurred, the
Tyr742 hydroxyl and the Ala768 methyl group are not within ste-
ric distances of each other. This finding supports the notion that
an ordered AL in this structure is correlated with activity and
Ser768 plays a critical role in the transition between ordered
and disordered AL. Interestingly, the position of the Ca of
Ser768 changed slightly depending on the way the enzyme is
active: the distance between the Ser768 Ca atom and the
Tyr742 hydroxyl oxygen atom was 2.24, 3.05, and 3.77 A˚ in the
JMS-lacking KIN structures, the YYFF:S768A mutant enzyme,
and the JMS-containing base-apo structure, respectively (Fig-
ure S1B). This suggests that the relative position of Ser768 in
the AL to Tyr742 directly reflects the current activity state of
the enzyme, such that the closer Ser768 is to aC, the more active
Figure 8. Kinase Activity and Structures of
EphA3 Mutants
(A) All proteins were purified under identical condi-
tions and pretreated with excess ATP and MgCl2
to fully phosphorylate the enzyme before kinetic
analysis as described in the Experimental Proce-
dures. All experiments were performed in dupli-
cate. For error bars, the standard error in Km and
kcat were propagated in order to show the resul-
tant error in kcat/Km.
(B) Presented in order of increasing activity are
three EphA3 mutants. The YYFF:Y742F model
has a disordered AL and ordered JMS region
and is nearly inactive compared to wild-type en-
zyme. The YYFF:S768A mutant has an ordered
AL and ordered JMS region and has recovered
almost complete activity relative to wild-type
enzyme. The YYFF:Y742A mutant has an ordered
AL and partially ordered JMS region and is nearly
three-fold more catalytically efficient than wild-
type enzyme.
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Structure of EphA3the enzyme. Minor torsional changes in the vicinity of Ser768 in-
duced by the interaction with Tyr742 could have a ripple effect on
the conformation of the neighboring region of the AL necessary
for substrate binding. The regulatory pathway might be extended
to the neighboring carbonyl oxygen of Leu767 and the side chain
of Arg769, both of which would be within hydrogen bonding
distance of the substrate binding pocket. The structures of the
triple mutant proteins may not recapitulate the conformational
changes induced by activating wild-type EphA3 kinase, how-
ever, these structures contribute to the greater understanding
of the changes that occur in the kinase upon activation, if only
to emphasize the complexity of the structural relationships
between the JMS, Tyr742, and the AL region.
Current models of the autoinhibition in Eph receptors focus on
the relationship between the JMS, the AL, and the N-terminal
lobe. Structural characterization of EphA3 and mutant forms of
the enzyme shows a complex relationship whereby the JMS af-
fects the AL through a pathway that includes Tyr742 (in the aE-b6
loop) and Ser768 (in the N-terminal AL). This model was sug-
gested by a number of our structures, where the hydroxyl groups
of Tyr742 and Ser768 seemingly clash in density. No major
conformational changes in the N-terminal lobe and its orientation
relative to the C-terminal lobe occurred with activation of the
enzyme, whether through autophosphorylation of the JMS, its
deletion, or mutagenesis of Ser768/Tyr742. In addition, the cur-
rent EphA3 structures all show consistently higher B-factors for
that face of the N-terminal lobe that would form interactions with
peptide substrates, and a correlation between increased tem-
perature factor and activity state is found (Figure 7). By using
B-factors as a measure of conformational flexibility, this analysis
suggests that activation of EphA3 kinase may occur mainly
through communication of activity state from the JMS to the
AL through Ser768 and that subtle changes in this molecular
pathway are propagated through regions of the enzyme that
are important for catalysis.
EXPERIMENTAL PROCEDURES
Cloning and Expression
The In-Fusion system (Clontech) was utilized to clone various constructs
encompassing the cytoplasmic region of ephA3 from cDNA obtained from
MGC (accession number BC063282) into a BseRI linearized pET28a-LIC
vector (GenBank: EF442785), which contains an N-terminal (His)6 tag and
thrombin cleavage site. For site-directed mutagenesis, the ephA3 gene was
amplified as two or three PCR products using mutagenic primers spanning
the altered codons. Resultant plasmids were transformed into BL21 Gold
(DE3) cells (Stratagene) for large scale protein expression. Cells were grown
in a supplemented Terrific Broth media at 37C to an OD600 of 5–6 and were
induced by adding 100 mM IPTG to the cultures. Cells were induced overnight
at 15C, then harvested and stored at 80C.
Purification and Concentration
Cell pellets from 4 l cultures were resuspended in 20 ml of lysis buffer (50 mM
Tris [pH 8.0], 500 mM NaCl, 1 mM PMSF, and 0.1 ml general protease inhibitor
Sigma P2714) and were homogenized for 30–60 sec per pellet. Cell lysis was
accomplished by sonication at 4C; lysed cells were centrifuged in a JA25.50
rotor in an Avanti J-20 XPI centrifuge (Beckman Coulter) for 20 min at
69,673 3 g. The supernatant was loaded onto 2 ml of Ni-NTA resin (QIAGEN
30450). Washes were 5 column volumes each of lysis buffer and low imidazole
buffer (lysis buffer plus 10 mM imidazole [pH 8]). Samples were eluted in 10 ml of
elution buffer (lysis buffer plus 250 mM imidazole and 10% glycerol). One unit
of thrombin (Sigma T9681) per milligram of protein was added to remove the882 Structure 16, 873–884, June 2008 ª2008 Elsevier Ltd All rights r(His)6 tag by incubation overnight at 4
C. For gel filtration, an XK 16365 column
(18-1031-47 and 18-6488-01, GE Healthcare) packed with HiLoad Superdex
200 resin (10-1043-04, GE Healthcare) was preequilibrated with gel filtration
buffer (lysis buffer plus 5 mM b-ME and 1 mM EDTA). Fractions were pooled
and concentrated using Amicon concentrators with a 10,000 molecular weight
cut-off (Millipore). For ATP-treated samples, the protein was concentrated to
250 mM and incubated overnight at 4C with 10 mM MgCl2 and 5–10 mM
ATP. For CIP-treated samples, the protein was concentrated to 250 mM
and mixed with alkaline phosphatase from calf intestinal mucosa (GE Health-
care, 27-0620-01). One-Phor-All Buffer PLUS and 100 units of phosphatase
were mixed with kinase and incubated at 4C overnight. Excess nucleotide
or other reagents were removed by running the protein mixture over a HiTrapQ
HP column (GE Healthcare, 17-1154-01) and pooling the peak fraction. In all
cases, EphA3 was used at 15–20 mg/ml for crystallization studies.
Crystallization, Data Collection, and Structure Solution
Crystals in several conditions of initial screens were noted; after optimization,
a set of conditions containing 22%–28% Peg 3350, 50 mM Tris (pH 7.5), and
40 mM (NH4)2SO4 was used. Soluble protein was obtained using a construct
containing residues Asp577–Ser947, and this protein produced large crystals
that diffracted well; subsequent mass spectrometry revealed that the protein
had degraded to construct boundaries corresponding to Thr595–Thr912.
Unfortunately, these construct boundaries do not produce soluble protein;
however, repeated purifications of the 577-947 protein always produced the
same degradation product, allowing for efficient reproduction of EphA3 crys-
tals and protein for enzymatic assays. See Figure 1A for constructs and
mutants used in the current study.
Optimization of initial crystallization conditions was performed by the hang-
ing drop vapor diffusion method on degraded protein, as described above.
Crystals typically appeared 24 hr after incubation at 18C; the typical size of
crystals was 4003 2003 200 microns. For crystals containing adenosine-im-
ido-triphosphate (AMP-PNP), cocrystallization trials were set up under condi-
tions of 15–20 mg/ml protein, 5 mM MgCl2, and 2 mM AMP-PNP (Sigma
A-2647). Crystals of kinase bound to AMP-PNP and crystals of mutant
EphA3 kinase formed under identical conditions as wild-type EphA3 and had
unit cell dimensions within 1% of wild-type. Crystals were harvested into cryo-
protection buffer (1:1 mixture of glycerol and mother liquor; final concentration
of glycerol was 15%) and frozen in liquid nitrogen. Diffraction data from crystals
of EphA3 were collected either using FR-E or RU-300 generators equipped with
RAXIS-IV++ detectors (Rigaku), MacCHESS beamline at Cornell High Energy
Synchrotron Source, or beamline 17ID at the Advanced Photon Source
(Argonne National Laboratory), and integrated and scaled using the HKL2000
program package (Minor et al., 2002; Otwinowski and Minor, 1997). Statistics
of data collection and processing are provided in Table 1 and Table S1.
For initial structure solution, a 2.3 A˚ resolution single-wavelength anomalous
diffraction data set was collected using a chromium anode equipped Rigaku
Ru-200, and the sulfur substructure was determined by the program SOLVE
(Terwilliger and Berendzen, 1999). Initial model building was performed with
RESOLVE (Terwilliger, 2001), followed by manual model building using the
graphics program O (Jones et al., 1991). A higher resolution data set using
the same crystal was obtained using a copper anode equipped FR-E diffrac-
tometer, and subsequent model building and refinement was performed using
the programs ARP/wARP (Perrakis et al., 1999), REFMAC5 (Bailey, 1994;
Potterton et al., 2003), and O, leading to a final R factor of 15.8% and Rfree
of 19.5% for data from 20 to 1.8 A˚. Translation, libration, screw (TLS) refine-
ment was performed in the final stages of refinement with parameters gener-
ated using the TLSMD web server (Painter and Merritt, 2006).
For all other structures of EphA3, data sets were processed using HKL2000
(Minor et al., 2002; Otwinowski and Minor, 1997) and phased using PHASER
(Read, 2001). Manual rebuilding was then performed using WinCoot (Emsley
and Cowtan, 2004) and refined using REFMAC (Bailey, 1994; Potterton
et al., 2003) in the CCP4i program suite. The coordinates and structure
factors for the initial structure of the kinase domain of human EphA3, and
subsequent structures of EphA3 as described in the text, have been deposited
into the PDB. All models have excellent stereochemistry as judged by
PROCHECK (Laskowski et al., 1993) and MOLPROBITY (Davis et al., 2004),
with no residues in disallowed or unfavorable regions of Ramachandraneserved
Structure
Structure of EphA3space. Statistics of model refinement for all fourteen structures are provided in
Table 1 and Table S1.
Kinase Assay
For all enzymatic assays presented in the current study, EphA3 protein was pre-
incubated with 10 mM each ATP and MgCl2 as described above in order to pro-
mote full autophosphorylation prior to assaying for enzymatic activity against
peptide substrates. All proteins were then purified using HiTrap Q as described
above in order to remove excess nucleotide from the reaction; then all proteins
were exchanged into identical reaction buffer by concentration and dilution.
Enzymatic activity of both wild-type and mutant EphA3 was determined using
the ADP-Quest Kit and following the protocol provided by DiscoveRx (Fremont,
CA). ADP production was followed by monitoring the increase in fluorescence
(excitation at 530 nm and emission at 590 nm) using a fluorescence plate reader
(Spectramax Gemini, Molecular Devices). All reactions were performed at room
temperature in a final volume of 50 ml. Kinetic constants for native EphA3 and its
mutants were determined by varying peptide (JM2; D598PHTYEDPTQ606) con-
centration from 31 to 1000 mM at 200 mM ATP. Protein concentrations of 50 nM
to 1 mM were used in the assay. All experiments were performed in duplicate,
and the values determined for kinase activity were corrected for background
ADP production. Km and Vmax values were calculated using the Michaelis-
Menten equation using Sigmaplot 9.0, and standard deviation was calculated
from two independent experiments. To measure the Km for ATP in Figure S4,
an optimized peptide substrate with higher affinity for EphA3 was used
(QDDNYE-PTR-IW) and ATP concentrations were varied (0–500 mM), whereas
protein concentrations were constant at 1 nM.
ACCESSION NUMBERS
The coordinates and structure factors for the initial structure of the kinase
domain of human EphA3 have been deposited into the PDB with ID 2GSF; sub-
sequent structures of EphA3 as described in the text have been deposited into
the PDB with codes 2QO2, 2QO7, 2QOQ, 2QO9, 2QOB, and 2QOC for wild-
type; and 2QOF, 2QOD, 2QOI, 2QOK, 2QOL, 2QON, and 2QOO for mutant
models.
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